EU MDR Clears Mosaic 3D as Cynosure Lutronic Scales Aesthetics
SEOUL, South Korea, Jan. 30, 2026 — Cynosure Lutronic announced the successful completion of European Union Medical Device Regulation...
AI in Healthcare Alzheimer’s Disease Bio-Pharma biologics biopharma biopharma innovation Biotechnology cancer therapy Cell Therapy cGxP Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development FDA fda approval FDA clearance GCP Gene Therapy GMP GMP compliance Immuno-Oncology immunology Immunotherapy Medical Devices MedTech medtech innovation Monoclonal Antibody Oncology oncology innovation Orphan Drug orphan drug designation patient access Phase 2 Trial Phase 3 trial Precision Medicine Precision Oncology rare disease rare diseases Regenerative Medicine regulatory approval regulatory compliance targeted therapy
SEOUL, South Korea, Jan. 30, 2026 — Cynosure Lutronic announced the successful completion of European Union Medical Device Regulation...
Nashville, Tenn., January 13, 2026 — Revance and Teoxane announced that the U.S. Food and Drug Administration has approved...
Peabody, Massachusetts | December 30, 2025 — Cosmetics & Wellness MD, formerly known as CosmeticsMD, announced a strategic expansion...
Laval, QC — December 1, 2025 — Bausch Health’s aesthetics division, Solta Medical, has completed the acquisition of Wuhan...
